SP-303 Small-particle aerosol treatment of influenza a virus infection in mice and respiratory syncytial virus infection in cotton rats
A natural plant product, SP-303, was administered by small-particle aerosol to influenza A/HK virus-infected mice and RSV-infected cotton rats. Aqueous SP-303 at 2 mg/ml in the Collison nebulizer reservoir generated an aerosol with an output of 26 μg/l and a particle size distribution of 1.4 μm ± 4....
Gespeichert in:
Veröffentlicht in: | Antiviral research 1993-05, Vol.21 (1), p.37-45 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 45 |
---|---|
container_issue | 1 |
container_start_page | 37 |
container_title | Antiviral research |
container_volume | 21 |
creator | Gilbert, Brian E. Wyde, Philip R. Wilson, Samuel Z. Meyerson, Laurence R. |
description | A natural plant product, SP-303, was administered by small-particle aerosol to influenza A/HK virus-infected mice and RSV-infected cotton rats. Aqueous SP-303 at 2 mg/ml in the Collison nebulizer reservoir generated an aerosol with an output of 26 μg/l and a particle size distribution of 1.4
μm ± 4.6 (MMAD±GSD). SP-303 at a dosage of 0.5–9.4 mg/kg per day administered for 3–4 days significantly increased both the rate and duration of survival of mice lethally infected with influenza A/HK virus. SP-303 was toxic to mice at 16 mg/kg per day as indicated by weight loss and a decrease in the duration of survival compared to control animals. From these data, a maximum therapeutic index (T.I.) of 12 was calculated. SP-303 given 3–4 days at dosages of 1.3–9.8 mg/kg per day was effective in reducing the pulmonary titer of RSV in infected cotton rats. However, at the 18.7 mg/kg per day dose a significant weight loss compared to control animals was observed; a T.I. of ⩽ 14 was estimated. These experiments demonstrate that aerosol administration of SP-303 was effective in the treatment of influenza A-infected mice and of RSV-infected cotton rats. |
doi_str_mv | 10.1016/0166-3542(93)90065-Q |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16616953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>016635429390065Q</els_id><sourcerecordid>16616953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-6343e8a15441e0a8a7bd96b82957b58b52b5960804147483acb38d95444f7ea23</originalsourceid><addsrcrecordid>eNp9kM-KFDEQh4O4rOPqGyjkIKKHXpNOupNcBFn8BwvrsnoO1elqiKTTY5JeGF_A196MM8xJPBRVpL5fET5CXnB2yRnv39XqG9HJ9o0Rbw1jfdfcPiIbrlXbGGb6x2RzQp6Qpzn_ZBVSRp-Tcy24Mi3fkD933xrBBL2bIYRmC6l4F5ACpiUvgZaEUGaMhS4T9XEKK8bfQIHe-7Tm_Qu64pdYJzp7V4NxpAnz1icoS9rRvItuVzyEfyXcUkqdKpqfkbMJQsbnx35Bfnz6-P3qS3N98_nr1YfrxkmuStMLKVAD76TkyECDGkbTD7o1nRo6PXTt0JmeaSa5VFILcIPQo6m4nBRCKy7I68PdbVp-rZiLnX12GAJEXNZsqzDem05UUB5AV03khJPdJj9D2lnO7N6_3cu1e7nWCPvXv72tsZfH--sw43gKHYXX_avjHrKDMCWIzucTJrUUnTIVe3_AsLq495hsdh6jw9Gn6s-Oi___Px4AwPKifA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16616953</pqid></control><display><type>article</type><title>SP-303 Small-particle aerosol treatment of influenza a virus infection in mice and respiratory syncytial virus infection in cotton rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gilbert, Brian E. ; Wyde, Philip R. ; Wilson, Samuel Z. ; Meyerson, Laurence R.</creator><creatorcontrib>Gilbert, Brian E. ; Wyde, Philip R. ; Wilson, Samuel Z. ; Meyerson, Laurence R.</creatorcontrib><description>A natural plant product, SP-303, was administered by small-particle aerosol to influenza A/HK virus-infected mice and RSV-infected cotton rats. Aqueous SP-303 at 2 mg/ml in the Collison nebulizer reservoir generated an aerosol with an output of 26 μg/l and a particle size distribution of 1.4
μm ± 4.6 (MMAD±GSD). SP-303 at a dosage of 0.5–9.4 mg/kg per day administered for 3–4 days significantly increased both the rate and duration of survival of mice lethally infected with influenza A/HK virus. SP-303 was toxic to mice at 16 mg/kg per day as indicated by weight loss and a decrease in the duration of survival compared to control animals. From these data, a maximum therapeutic index (T.I.) of 12 was calculated. SP-303 given 3–4 days at dosages of 1.3–9.8 mg/kg per day was effective in reducing the pulmonary titer of RSV in infected cotton rats. However, at the 18.7 mg/kg per day dose a significant weight loss compared to control animals was observed; a T.I. of ⩽ 14 was estimated. These experiments demonstrate that aerosol administration of SP-303 was effective in the treatment of influenza A-infected mice and of RSV-infected cotton rats.</description><identifier>ISSN: 0166-3542</identifier><identifier>EISSN: 1872-9096</identifier><identifier>DOI: 10.1016/0166-3542(93)90065-Q</identifier><identifier>PMID: 8317921</identifier><identifier>CODEN: ARSRDR</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Administration, Inhalation ; Aerosol ; Aerosols ; Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - pharmacokinetics ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Biopolymers ; Catechin - analogs & derivatives ; Catechin - pharmacokinetics ; Catechin - pharmacology ; Cotton rats ; Dose-Response Relationship, Drug ; Humans ; Influenza A virus ; Influenza virus ; Influenza, Human - drug therapy ; Influenza, Human - microbiology ; Medical sciences ; Mice ; Mice, Inbred ICR ; Pharmacology. Drug treatments ; Plant Extracts - pharmacology ; Rats ; respiratory syncytial virus ; Respiratory Syncytial Viruses ; Respirovirus Infections - drug therapy ; Respirovirus Infections - microbiology ; Ribavirin ; RSV ; SP-303 ; Therapeutic Equivalency</subject><ispartof>Antiviral research, 1993-05, Vol.21 (1), p.37-45</ispartof><rights>1993</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-6343e8a15441e0a8a7bd96b82957b58b52b5960804147483acb38d95444f7ea23</citedby><cites>FETCH-LOGICAL-c417t-6343e8a15441e0a8a7bd96b82957b58b52b5960804147483acb38d95444f7ea23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/016635429390065Q$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4843579$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8317921$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilbert, Brian E.</creatorcontrib><creatorcontrib>Wyde, Philip R.</creatorcontrib><creatorcontrib>Wilson, Samuel Z.</creatorcontrib><creatorcontrib>Meyerson, Laurence R.</creatorcontrib><title>SP-303 Small-particle aerosol treatment of influenza a virus infection in mice and respiratory syncytial virus infection in cotton rats</title><title>Antiviral research</title><addtitle>Antiviral Res</addtitle><description>A natural plant product, SP-303, was administered by small-particle aerosol to influenza A/HK virus-infected mice and RSV-infected cotton rats. Aqueous SP-303 at 2 mg/ml in the Collison nebulizer reservoir generated an aerosol with an output of 26 μg/l and a particle size distribution of 1.4
μm ± 4.6 (MMAD±GSD). SP-303 at a dosage of 0.5–9.4 mg/kg per day administered for 3–4 days significantly increased both the rate and duration of survival of mice lethally infected with influenza A/HK virus. SP-303 was toxic to mice at 16 mg/kg per day as indicated by weight loss and a decrease in the duration of survival compared to control animals. From these data, a maximum therapeutic index (T.I.) of 12 was calculated. SP-303 given 3–4 days at dosages of 1.3–9.8 mg/kg per day was effective in reducing the pulmonary titer of RSV in infected cotton rats. However, at the 18.7 mg/kg per day dose a significant weight loss compared to control animals was observed; a T.I. of ⩽ 14 was estimated. These experiments demonstrate that aerosol administration of SP-303 was effective in the treatment of influenza A-infected mice and of RSV-infected cotton rats.</description><subject>Administration, Inhalation</subject><subject>Aerosol</subject><subject>Aerosols</subject><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - pharmacokinetics</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biopolymers</subject><subject>Catechin - analogs & derivatives</subject><subject>Catechin - pharmacokinetics</subject><subject>Catechin - pharmacology</subject><subject>Cotton rats</subject><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>Influenza A virus</subject><subject>Influenza virus</subject><subject>Influenza, Human - drug therapy</subject><subject>Influenza, Human - microbiology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred ICR</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - pharmacology</subject><subject>Rats</subject><subject>respiratory syncytial virus</subject><subject>Respiratory Syncytial Viruses</subject><subject>Respirovirus Infections - drug therapy</subject><subject>Respirovirus Infections - microbiology</subject><subject>Ribavirin</subject><subject>RSV</subject><subject>SP-303</subject><subject>Therapeutic Equivalency</subject><issn>0166-3542</issn><issn>1872-9096</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM-KFDEQh4O4rOPqGyjkIKKHXpNOupNcBFn8BwvrsnoO1elqiKTTY5JeGF_A196MM8xJPBRVpL5fET5CXnB2yRnv39XqG9HJ9o0Rbw1jfdfcPiIbrlXbGGb6x2RzQp6Qpzn_ZBVSRp-Tcy24Mi3fkD933xrBBL2bIYRmC6l4F5ACpiUvgZaEUGaMhS4T9XEKK8bfQIHe-7Tm_Qu64pdYJzp7V4NxpAnz1icoS9rRvItuVzyEfyXcUkqdKpqfkbMJQsbnx35Bfnz6-P3qS3N98_nr1YfrxkmuStMLKVAD76TkyECDGkbTD7o1nRo6PXTt0JmeaSa5VFILcIPQo6m4nBRCKy7I68PdbVp-rZiLnX12GAJEXNZsqzDem05UUB5AV03khJPdJj9D2lnO7N6_3cu1e7nWCPvXv72tsZfH--sw43gKHYXX_avjHrKDMCWIzucTJrUUnTIVe3_AsLq495hsdh6jw9Gn6s-Oi___Px4AwPKifA</recordid><startdate>19930501</startdate><enddate>19930501</enddate><creator>Gilbert, Brian E.</creator><creator>Wyde, Philip R.</creator><creator>Wilson, Samuel Z.</creator><creator>Meyerson, Laurence R.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>19930501</creationdate><title>SP-303 Small-particle aerosol treatment of influenza a virus infection in mice and respiratory syncytial virus infection in cotton rats</title><author>Gilbert, Brian E. ; Wyde, Philip R. ; Wilson, Samuel Z. ; Meyerson, Laurence R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-6343e8a15441e0a8a7bd96b82957b58b52b5960804147483acb38d95444f7ea23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Administration, Inhalation</topic><topic>Aerosol</topic><topic>Aerosols</topic><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - pharmacokinetics</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biopolymers</topic><topic>Catechin - analogs & derivatives</topic><topic>Catechin - pharmacokinetics</topic><topic>Catechin - pharmacology</topic><topic>Cotton rats</topic><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>Influenza A virus</topic><topic>Influenza virus</topic><topic>Influenza, Human - drug therapy</topic><topic>Influenza, Human - microbiology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred ICR</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - pharmacology</topic><topic>Rats</topic><topic>respiratory syncytial virus</topic><topic>Respiratory Syncytial Viruses</topic><topic>Respirovirus Infections - drug therapy</topic><topic>Respirovirus Infections - microbiology</topic><topic>Ribavirin</topic><topic>RSV</topic><topic>SP-303</topic><topic>Therapeutic Equivalency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilbert, Brian E.</creatorcontrib><creatorcontrib>Wyde, Philip R.</creatorcontrib><creatorcontrib>Wilson, Samuel Z.</creatorcontrib><creatorcontrib>Meyerson, Laurence R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Antiviral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilbert, Brian E.</au><au>Wyde, Philip R.</au><au>Wilson, Samuel Z.</au><au>Meyerson, Laurence R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SP-303 Small-particle aerosol treatment of influenza a virus infection in mice and respiratory syncytial virus infection in cotton rats</atitle><jtitle>Antiviral research</jtitle><addtitle>Antiviral Res</addtitle><date>1993-05-01</date><risdate>1993</risdate><volume>21</volume><issue>1</issue><spage>37</spage><epage>45</epage><pages>37-45</pages><issn>0166-3542</issn><eissn>1872-9096</eissn><coden>ARSRDR</coden><abstract>A natural plant product, SP-303, was administered by small-particle aerosol to influenza A/HK virus-infected mice and RSV-infected cotton rats. Aqueous SP-303 at 2 mg/ml in the Collison nebulizer reservoir generated an aerosol with an output of 26 μg/l and a particle size distribution of 1.4
μm ± 4.6 (MMAD±GSD). SP-303 at a dosage of 0.5–9.4 mg/kg per day administered for 3–4 days significantly increased both the rate and duration of survival of mice lethally infected with influenza A/HK virus. SP-303 was toxic to mice at 16 mg/kg per day as indicated by weight loss and a decrease in the duration of survival compared to control animals. From these data, a maximum therapeutic index (T.I.) of 12 was calculated. SP-303 given 3–4 days at dosages of 1.3–9.8 mg/kg per day was effective in reducing the pulmonary titer of RSV in infected cotton rats. However, at the 18.7 mg/kg per day dose a significant weight loss compared to control animals was observed; a T.I. of ⩽ 14 was estimated. These experiments demonstrate that aerosol administration of SP-303 was effective in the treatment of influenza A-infected mice and of RSV-infected cotton rats.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>8317921</pmid><doi>10.1016/0166-3542(93)90065-Q</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0166-3542 |
ispartof | Antiviral research, 1993-05, Vol.21 (1), p.37-45 |
issn | 0166-3542 1872-9096 |
language | eng |
recordid | cdi_proquest_miscellaneous_16616953 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Administration, Inhalation Aerosol Aerosols Animals Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - pharmacokinetics Antiviral Agents - pharmacology Biological and medical sciences Biopolymers Catechin - analogs & derivatives Catechin - pharmacokinetics Catechin - pharmacology Cotton rats Dose-Response Relationship, Drug Humans Influenza A virus Influenza virus Influenza, Human - drug therapy Influenza, Human - microbiology Medical sciences Mice Mice, Inbred ICR Pharmacology. Drug treatments Plant Extracts - pharmacology Rats respiratory syncytial virus Respiratory Syncytial Viruses Respirovirus Infections - drug therapy Respirovirus Infections - microbiology Ribavirin RSV SP-303 Therapeutic Equivalency |
title | SP-303 Small-particle aerosol treatment of influenza a virus infection in mice and respiratory syncytial virus infection in cotton rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A35%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SP-303%20Small-particle%20aerosol%20treatment%20of%20influenza%20a%20virus%20infection%20in%20mice%20and%20respiratory%20syncytial%20virus%20infection%20in%20cotton%20rats&rft.jtitle=Antiviral%20research&rft.au=Gilbert,%20Brian%20E.&rft.date=1993-05-01&rft.volume=21&rft.issue=1&rft.spage=37&rft.epage=45&rft.pages=37-45&rft.issn=0166-3542&rft.eissn=1872-9096&rft.coden=ARSRDR&rft_id=info:doi/10.1016/0166-3542(93)90065-Q&rft_dat=%3Cproquest_cross%3E16616953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16616953&rft_id=info:pmid/8317921&rft_els_id=016635429390065Q&rfr_iscdi=true |